Holen Sie sich die Stockscreener-App
2.58
0.00%
0.00
Handel nachbörslich:
2.60
0.02
+0.78%
Schlusskurs vom Vortag:
$2.58
Offen:
$2.59
24-Stunden-Volumen:
58,271
Relative Volume:
0.06
Marktkapitalisierung:
$4.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.52M
KGV:
-0.1389
EPS:
-18.58
Netto-Cashflow:
$-16.61M
1W Leistung:
+8.40%
1M Leistung:
-10.10%
6M Leistung:
-39.72%
1J Leistung:
-81.99%
1-Tages-Spanne:
$2.53
$2.6186
1-Wochen-Bereich:
$2.26
$2.6186
52-Wochen-Spanne:
$0.702
$56.00
Revelation Biosciences Inc Stock (REVB) Company Profile
Firmenname
Revelation Biosciences Inc
Sektor
Branche
Telefon
650-800-3717
Adresse
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Vergleichen Sie REVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
2.58 | 4.39M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Aktie (REVB) Neueste Nachrichten
Can trapped investors hope for a rebound in Revelation Biosciences Inc.July 2025 Recap & Capital Efficient Trade Techniques - Newser
Measuring Revelation Biosciences Inc. Equity Warrant’s beta against major indicesJuly 2025 Final Week & Expert Approved Trade Ideas - Newser
Does Revelation Biosciences Inc. have declining or rising EPSJuly 2025 Rallies & High Accuracy Trade Alerts - thegnnews.com
Published on: 2025-08-17 03:23:14 - Newser
Will Revelation Biosciences Inc. Equity Warrant benefit from macro trendsJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - Newser
Custom watchlist performance reports with Revelation Biosciences Inc.Portfolio Update Report & Weekly High Potential Stock Alerts - Newser
Why Revelation Biosciences Inc. Equity Warrant stock attracts strong analyst attention2025 Key Highlights & High Return Stock Watch Alerts - Newser
How Revelation Biosciences Inc. stock performs during market volatilityInsider Buying & Daily Entry Point Trade Alerts - Newser
Is Revelation Biosciences Inc. Equity Warrant a candidate for recovery playCEO Change & AI Based Buy and Sell Signals - Newser
Is it too late to sell Revelation Biosciences Inc.2025 Retail Activity & Free Daily Entry Point Trade Alerts - Newser
Tick level data insight on Revelation Biosciences Inc. volatility2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc. Equity Warrant - Newser
What MACD signals say about Revelation Biosciences Inc.Earnings Performance Report & Risk Managed Investment Entry Signals - Newser
Exit strategy if you’re trapped in Revelation Biosciences Inc. Equity WarrantEarnings Miss & AI Driven Stock Price Forecasts - Newser
Using Ichimoku Cloud for Revelation Biosciences Inc. Equity Warrant technicals2025 Momentum Check & Daily Stock Momentum Reports - Newser
Published on: 2025-08-16 02:57:08 - Newser
How to monitor Revelation Biosciences Inc. Equity Warrant with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Revelation Biosciences Inc. Equity Warrant2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
Will breakout in Revelation Biosciences Inc. Equity Warrant lead to full recovery2025 Bull vs Bear & Daily Entry Point Trade Alerts - Newser
How moving averages guide Revelation Biosciences Inc. tradingJuly 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
Will Revelation Biosciences Inc. benefit from macro trends2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Statistical indicators supporting Revelation Biosciences Inc.’s strengthMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Backtesting results for Revelation Biosciences Inc. Equity Warrant trading strategies - Newser
Top chart patterns to watch in Revelation Biosciences Inc. Equity WarrantWeekly Stock Report & Weekly Setup with High ROI Potential - Newser
How to build a custom watchlist for Revelation Biosciences Inc.Weekly Trade Review & Safe Entry Momentum Stock Tips - Newser
Regression analysis insights on Revelation Biosciences Inc. Equity Warrant performance2025 Trading Recap & Long Hold Capital Preservation Tips - Newser
Custom watchlist performance reports with Revelation Biosciences Inc. Equity WarrantMarket Risk Analysis & Consistent Profit Trading Strategies - Newser
Quantitative breakdown of Revelation Biosciences Inc. recent moveQuarterly Profit Review & Short-Term High Return Strategies - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc.2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - Newser
Is Revelation Biosciences Inc. stock entering bullish territoryQuarterly Market Review & Real-Time Volume Trigger Notifications - Newser
Is Revelation Biosciences Inc. a defensive stockEarnings Overview Summary & AI Enhanced Market Trend Forecasts - thegnnews.com
Applying chart zones and confluence areas to Revelation Biosciences Inc. Equity WarrantGold Moves & High Accuracy Investment Signals - Newser
Does Revelation Biosciences Inc. outperform in volatile marketsEarnings Performance Report & Risk Adjusted Swing Trade Ideas - sundaytimes.kr
What analysts say about Revelation Biosciences Inc. stock2025 Technical Overview & Weekly Momentum Stock Picks - thegnnews.com
What makes Revelation Biosciences Inc. stock price move sharplyWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Published on: 2025-08-15 11:15:13 - sundaytimes.kr
Long term hold vs stop loss in Revelation Biosciences Inc.2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Published on: 2025-08-14 01:40:36 - Newser
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):